Ana Navarro, a political commentator and guest host on The View, revealed her weight loss journey during the show's 30th anniversary season debut. She humorously credited her significant weight loss to the diabetes medication Mounjaro, alongside sharing insights into her healthy…
Recent studies indicate that GLP-1 obesity injections, including Ozempic and Mounjaro, may not be effective for all individuals, with some participants failing to achieve signific…
A recent review in JAMA Otolaryngology highlights the potential benefits of GLP-1 weight-loss drugs, such as tirzepatide, in reducing the severity of obesity-related sleep apnea.…
Recent research presented at the Endocrine Society’s ENDO 2026 meeting reveals that individuals taking GLP-1 weight loss medications, such as Ozempic and Wegovy, not only lost wei…
As GLP-1 medications gain popularity for weight loss, many users face the dilemma of whether they can stop the injections without regaining weight. Experts highlight the risks ass…
The FDA has granted approval for Mounjaro (tirzepatide) to reduce cardiovascular risk in individuals with type 2 diabetes, marking a significant development in diabetes management…
As metabolic health gains prominence in wellness discussions, the roles of NAD+ and GLP-1 therapies are increasingly scrutinized. This article clarifies how GLP-1 medications like…
Eli Lilly has reported a significant revenue increase of 47% in the second quarter, reaching $22.97 billion, despite a decline in employer insurance coverage for GLP-1 weight-loss…
The FDA has approved Eli Lilly's medication Mounjaro for reducing the risk of heart events in individuals with Type 2 diabetes. This approval adds to the drug's existing use for b…
This article examines the potential of GLP-1 receptor agonists, commonly used for type 2 diabetes and obesity, in treating polyendocrine metabolic ovarian syndrome (PMOS). Experts…
An inquest into the death of 73-year-old Caroline Savage revealed that doctors did not focus solely on her use of the weight-loss drug Mounjaro when assessing her symptoms. The co…
Researchers at UC Berkeley have discovered that the compound TOFA can enhance energy expenditure and reduce body fat without causing muscle loss in mice. This approach contrasts w…
NVIDIA and Eli Lilly have both reported impressive quarterly earnings, showcasing their respective growth potential. NVIDIA's revenue surged by over 105% year-over-year, driven by…
The beauty industry is rapidly evolving in response to the adoption of GLP-1 weight-loss drugs, creating a new market for beauty products that promise to counteract the side effec…
In a stunning twist of regulatory fate, the FDA has issued new hair-raising guidelines for users of GLP-1 drugs like Ozempic and Mounjaro, warning of a 37-68% increased risk of ha…